Autopsy report · NCT03337152

Assessing a Risk Model for G6PD Deficiency

“study met study halting rules”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 5 months before it stopped.
• 54 participants enrolled.
• Results were posted on the registry 3 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

PATH

Sponsor type

University, hospital or other

Conditions

Malaria, Vivax; G6PD Deficiency

Interventions

primaquine; chloroquine + primaquine

Participants

54

Sites

1

Countries

Thailand

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.